New Anthracenedione Derivatives with Improved Biological Activity by Virtue of Stable Drug− DNA Adduct Formation
…, KG Watson, A Nudelman, A Rephaeli…
Index: Mansour, Oula C.; Evison, Benny J.; Sleebs, Brad E.; Watson, Keith G.; Nudelman, Abraham; Rephaeli, Ada; Buck, Damian P.; Collins, J. Grant; Bilardi, Rebecca A.; Phillips, Don R.; Cutts, Suzanne M. Journal of Medicinal Chemistry, 2010 , vol. 53, # 19 p. 6851 - 6866
Full Text: HTML
Citation Number: 16
Abstract
Mitoxantrone is an anticancer agent that acts as a topoisomerase II poison, however, it can also be activated by formaldehyde to form DNA adducts. Pixantrone, a 2-aza- anthracenedione with terminal primary amino groups in its side chains, forms formaldehyde- mediated adducts with DNA more efficiently than mitoxantrone. Molecular modeling studies indicated that extension of the “linker” region of anthracenedione side arms would allow ...
Related Articles:
[Hsin, Ling-Wei; Wang, Hui-Po; Kao, Pi-Hung; Lee, On; Chen, Wan-Ru; Chen, Hung-Wei; Guh, Jih-Hwa; Chan, Ya-Ling; His, Chin-Ping; Yang, Ming-Show; Li, Tsai-Kun; Lee, Chieh-Hua Bioorganic and Medicinal Chemistry, 2008 , vol. 16, # 2 p. 1006 - 1014]
Antitumor agents. 1. 1, 4-Bis [(aminoalkyl) amino]-9, 10-anthracenediones
[Murdock,K.C. et al. Journal of Medicinal Chemistry, 1979 , vol. 22, # 9 p. 1024 - 1030]